Recommended Reading on Myocardial Function

ESC Working Group on Myocardial Function

Date

Title

• Date: 21/04/2025
  Title: Cardioprotective effects of semaglutide on isolated human ventricular myocardium
• Date: 21/04/2025
  Title: Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart.
• Date: 21/04/2025
  Title: Autophagy is required for the therapeutic effects of the NAD+ precursor nicotinamide in obesity-related heart failure with preserved ejection fraction
• Date: 01/02/2025
  Title: Heart Failure with Preserved Ejection Fraction.
• Date: 01/02/2025
  Title: Fibroblast-specific TGF-β signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice
• Date: 01/02/2025
  Title: The year in cardiovascular medicine 2024: the top 10 papers in heart failure
• Date: 01/12/2024
  Title: Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond.
• Date: 01/12/2024
  Title: Circulating beta-hydroxybutyrate levels in advanced heart failure with reduced ejection fraction: Determinants and prognostic impact
• Date: 01/12/2024
  Title: Clinical trials in-a-dish for cardiovascular medicine
• Date: 01/10/2024
  Title: Mechanisms of myocardial reverse remodelling and its clinical significance
• Date: 01/10/2024
  Title: The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischaemic heart failure
• Date: 01/10/2024
  Title: Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice.
• Date: 08/05/2023
  Title: Years of cardiovascular complications and risk factors in patients with type 2 diabetes: A nationwide swedish cohort study
• Date: 18/04/2023
  Title: Obesity induced inflammation exacerbates clonal hematopoiesis
• Date: 01/02/2023
  Title: Prospective association of daily steps with cardiovascular disease: a harmonized meta-analysis
• Date: 01/02/2023
  Title: Ablation of CaMKIIδ oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease
• Date: 01/02/2023
  Title: Hallmarks of aging: An expanding universe
• Date: 01/04/2022
  Title: Small molecule STING inhibition improves myocardial infarction remodeling
• Date: 01/04/2022
  Title: Bone morphogenetic protein 1.3 inhibition decreases scar formation and supports cardiomyocyte survival after myocardial infarction
• Date: 01/12/2021
  Title: Muscle repair after physiological damage relies on nuclear migration for cellular reconstruction
• Date: 01/12/2021
  Title: Inhibition of phosphodiesterase type 9 reduces obesity and cardiometabolic syndrome in mice
• Date: 01/12/2021
  Title: Truncated titin proteins and titin haploinsufficiency are targets for functional recovery in human cardiomyopathy due to TTN mutations
• Date: 14/10/2021
  Title: Cardiomyocytes disrupt pyrimidine biosynthesis in nonmyocytes to regulate heart repair
• Date: 14/10/2021
  Title: Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis
• Date: 07/09/2021
  Title: Genomic instability in the naturally and prematurely aged myocardium
• Date: 21/08/2021
  Title: PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction
• Date: 02/08/2021
  Title: Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies
• Date: 02/08/2021
  Title: Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF
• Date: 20/04/2021
  Title: Stress-dependent activation of myosin in the heart requires thin filament activation and thick filament mechanosensing
• Date: 17/04/2021
  Title: Genetic blockade of lymphangiogenesis does not impair cardiac function after myocardial infarction
• Date: 15/04/2021
  Title: BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection
• Date: 09/03/2021
  Title: Discordant clinical features of identical hypertrophic cardiomyopathy twins
• Date: 24/02/2021
  Title: Use of stable isotope-tagged thymidine and multi-isotope imaging mass spectrometry (MIMS) for quantification of human cardiomyocyte division
• Date: 22/02/2021
  Title: Reciprocal organ interactions during heart failure-a position paper from the ESC working group on myocardial function
• Date: 10/02/2021
  Title: Nicotinamide for the treatment of heart failure with preserved ejection fraction
• Date: 09/12/2020
  Title: Lymphoangiocrine signals promote cardiac growth and repair
• Date: 20/10/2020
  Title: CHIP phosphorylation by protein kinase G enhances protein quality control and attenuates cardiac ischemic injury
• Date: 20/10/2020
  Title: CHIP phosphorylation by protein kinase G enhances protein quality control and attenuates cardiac ischemic injury
• Date: 16/10/2020
  Title: Comprehensive quantification of fuel use by the failing and nonfailing human heart
• Date: 09/10/2020
  Title: CaMKIIδC Drives Early Adaptive Ca 2+ Change and Late Eccentric Cardiac Hypertrophy
• Date: 24/09/2020
  Title: Cells of the adult human heart
• Date: 15/09/2020
  Title: A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart
• Date: 22/05/2020
  Title: Cardiac natriuretic peptides
• Date: 19/05/2020
  Title: Matrix-transmitted paratensile signaling enables myofibroblast-fibroblast cross talk in fibrosis expansion
• Date: 07/05/2020
  Title: Cardiac Mechano-Electric Coupling: Acute Effects of Mechanical Stimulation on Heart Rate and Rhythm
• Date: 07/04/2020
  Title: Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects
• Date: 03/03/2020
  Title: Diminished Reactive Hematopoiesis and Cardiac Inflammation in a Mouse Model of Recurrent Myocardial Infarction
• Date: 28/02/2020
  Title: Genome-wide association and multi-omic analyses reveal ACTN2 as a gene linked to heart failure
• Date: 03/02/2020
  Title: Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine
• Date: 28/11/2019
  Title: Direct Sarcomere Modulators Are Promising New Treatments for Cardiomyopathies
• Date: 19/11/2019
  Title: A single combination gene therapy treats multiple age-related diseases
• Date: 15/11/2019
  Title: Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy
• Date: 16/10/2019
  Title: CaM kinase II regulates cardiac hemoglobin expression through histone phosphorylation upon sympathetic activation
• Date: 07/10/2019
  Title: Cronos Titin Is Expressed in Human Cardiomyocytes and Necessary for Normal Sarcomere Functio
• Date: 02/08/2019
  Title: 3D bioprinting of collagen to rebuild components of the human heart
• Date: 31/05/2019
  Title: Oligogenic inheritance of a human heart disease involving a genetic modifier
• Date: 08/05/2019
  Title: MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs
• Date: 01/05/2019
  Title: Relaxin-2 for heart failure with preserved ejection fraction (HFpEF): Rationale for future clinical trials
• Date: 10/04/2019
  Title: Nitrosative stress drives heart failure with preserved ejection fraction
• Date: 08/04/2019
  Title: The continuous heart failure spectrum: moving beyond an ejection fraction classification
• Date: 21/02/2019
  Title: The BAG3-dependent and -independent roles of cardiac small heat shock proteins
• Date: 10/01/2019
  Title: Long-term functional and structural preservation of precision-cut human myocardium under continuous electromechanical stimulation in vitro
• Date: 31/10/2018
  Title: Cardiac Disorders and Pathophysiology of Sarcomeric Proteins
• Date: 17/10/2018
  Title: Empagliflozin directly improves diastolic function in human heart failure
• Date: 20/09/2018
  Title: Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes
• Date: 25/01/2018
  Title: Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-life-threatening arrhythmias